Pages

Tuesday, March 21, 2017

Imprimis Challenges Mallinckrodt's Acthar

Benzinga-6 hours ago
"It's apparent that efforts by policymakers to lower drug costs have been in vain," Imprimis said Tuesday. "It is only when there is competition or threats of ...